Also trades as: 4543.T (JPX) · $vol 72M · TRUMY (OTC) · $vol 1M

$14.06

+0.56 (+4.15%)

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 45 · $20.7B mcap · 1.45B float · 0.0001% daily turnover · Short 84% of daily vol

Revenue

$1.14T +9.9% ▲

5Y CAGR: +13.2%

Gross Profit

$598.4B +6.7% ▲

5Y CAGR: +12.9%

Operating Income

$185.9B +17.9% ▲

5Y CAGR: +13.6%

Net Income

$136.8B +16.9% ▲

5Y CAGR: +12.1%

EPS (Diluted)

$92.67 +17.3% ▲

5Y CAGR: +12.7%

EBITDA

$281.9B +14.5% ▲

5Y CAGR: +13.0%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$703.3B	$820.2B	$921.9B	$1.04T	$1.14T
YoY Growth	+14.6%	+16.6%	+12.4%	+12.4%	+9.9%
Cost of Revenue	$334.0B	$402.8B	$442.7B	$475.5B	$540.6B
Gross Profit	$369.3B	$417.4B	$479.2B	$560.7B	$598.4B
Gross Margin	52.5%	50.9%	52.0%	54.1%	52.5%
R&D Expenses	$0	$0	$83.6B	$0	$0
SG&A Expenses	$250.9B	$299.9B	$343.7B	$381.6B	$412.5B
Operating Expenses	$253.4B	$300.0B	$339.1B	$403.0B	$412.5B
Operating Income	$116.0B	$117.3B	$140.1B	$157.7B	$185.9B
Operating Margin	16.5%	14.3%	15.2%	15.2%	16.3%
Interest Expense	$3.0B	$4.0B	$2.8B	$6.2B	$3.3B
Income Before Tax	$114.5B	$116.1B	$140.8B	$154.6B	$179.4B
Tax Expense	$25.7B	$26.8B	$34.5B	$37.6B	$42.6B
Net Income	$88.8B	$89.3B	$106.4B	$117.0B	$136.8B
Net Margin	12.6%	10.9%	11.5%	11.3%	12.0%
EPS (Diluted)	$58.69	$59.48	$71.47	$78.99	$92.67
EBITDA	$175.5B	$190.4B	$220.3B	$246.3B	$281.9B
Shares Outstanding	1.51B	1.50B	1.49B	1.48B	1.48B

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$258.2B	$250.5B	$263.6B	$263.9B	$260.0B	$278.9B	$296.9B	$302.2B
Cost of Revenue	$120.6B	$111.0B	$118.4B	$125.4B	$114.5B	$129.8B	$143.6B	$152.3B
Gross Profit	$137.6B	$139.5B	$145.1B	$138.5B	$145.5B	$149.1B	$153.3B	$150.0B
Gross Margin	53.3%	55.7%	55.1%	52.5%	56.0%	53.5%	51.6%	49.6%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$92.2B	$92.6B	$96.3B	$100.6B	$92.0B	$99.3B	$105.4B	$115.5B
Operating Expenses	$92.9B	$91.8B	$99.3B	$114.4B	$89.6B	$99.3B	$105.4B	$115.5B
Operating Income	$44.6B	$47.6B	$45.8B	$24.2B	$55.9B	$49.8B	$48.0B	$34.4B
Operating Margin	17.3%	19.0%	17.4%	9.2%	21.5%	17.9%	16.2%	11.4%
Interest Expense	$568M	$3.4B	$0	$1.4B	$405M	$18M	$463M	$1.5B
Income Before Tax	$45.6B	$39.5B	$46.7B	$22.7B	$55.3B	$46.6B	$45.4B	$31.9B
Tax Expense	$11.7B	$10.2B	$11.3B	$4.4B	$13.4B	$11.1B	$12.7B	$5.3B
Net Income	$33.9B	$29.3B	$35.4B	$18.4B	$41.8B	$35.6B	$32.7B	$26.5B
Net Margin	13.1%	11.7%	13.4%	7.0%	16.1%	12.7%	11.0%	8.8%
EPS (Diluted)	$22.82	$19.74	$23.96	$12.44	$28.36	$24.00	$21.96	$17.58
EBITDA	$65.6B	$63.9B	$67.9B	$64.3B	$77.1B	$68.8B	$74.1B	$61.0B
Shares Outstanding	1.49B	1.49B	1.48B	1.48B	1.48B	1.48B	1.48B	1.48B

TRUMF OTC